Citigroup Reduces Stake in Chemours

Institutional investor sells over 129,000 shares of specialty chemicals company

Published on Mar. 5, 2026

Got story updates? Submit your updates here. ›

Citigroup Inc. has reduced its stake in The Chemours Company (NYSE:CC) by 32% in the third quarter, according to a recent SEC filing. The firm sold 129,646 shares, leaving it with 275,184 shares worth $4.36 million, or 0.18% of the company's stock.

Why it matters

Chemours is a major specialty chemicals company, and changes in institutional ownership can signal shifts in market sentiment around the stock. Citigroup's reduced position may indicate broader concerns about the company's performance or outlook.

The details

According to the filing, Citigroup sold 129,646 shares of Chemours stock during the third quarter, reducing its total position to 275,184 shares. The firm now owns 0.18% of Chemours' outstanding shares. Other institutional investors have also made changes to their Chemours positions, with some increasing and others decreasing their stakes.

  • Citigroup reduced its Chemours stake in the 3rd quarter of 2026.

The players

Citigroup Inc.

A major global financial services company that provides a wide range of banking, investment, and financial products and services.

The Chemours Company

A specialty chemicals company that was spun off from DuPont in 2015, focused on performance chemicals, titanium technologies, and chemical solutions.

Got photos? Submit your photos here. ›

The takeaway

Citigroup's reduced stake in Chemours could signal broader market concerns about the specialty chemicals company's performance or outlook, though the reasons behind the sell-off are not entirely clear from the limited information provided.